Olema Pharmaceuticals (NASDAQ:OLMA) and Arcutis Biotherapeutics (NASDAQ:ARQT) Critical Contrast themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) has earned an average recommendation of “Buy” from the six research firms that are covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price objective among analysts that have covered the stock in the […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded up 8.3% during mid-day trading on Wednesday . The company traded as high as $17.20 and last traded at $17.20. 34,407 shares were traded during trading, a decline of 88% from the average session volume of 288,567 shares. The stock had previously closed at $15.88. Wall […]
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities researchers at Capital One Financial increased their FY2023 EPS estimates for Olema Pharmaceuticals in a research report issued to clients and investors on Monday, November 13th. Capital One Financial analyst Z. Jallah now anticipates that the company will post earnings per share of ($2.22) for the […]
Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Get Free Report) traded up 8.3% during trading on Wednesday . The company traded as high as $17.20 and last traded at $17.20. 34,407 shares changed hands during trading, a decline of 88% from the average session volume of 288,567 shares. The stock had previously closed at $15.88. […]